Philips delivers ‘good start to 2026,’ CEO says
By HME News Staff
Updated 9:49 AM CDT, Wed May 6, 2026
AMSTERDAM – Philips reported group sales of EUR 3.9 billion for the first quarter of 2026, a 4% increase compared to the same period last year. Sales for Connected Care, which includes the Sleep and Respiratory Care segment, increased 3%.
Other financial results:
- Comparable order intake growth 6%
- Income from operations increased to EUR 241 million
- Adjusted EBITA margin increased 40 basis points to 9.0%
- Operating cash flow of EUR 188 million, with free cash flow of EUR 28 million
“We delivered a good start to 2026, with strong order intake growth at 6%, comparable sales growth of 4% and margin expansion of 40 basis points, reflecting disciplined execution against our plan in an uncertain macro-environment,” said CEO Roy Jakobs. “Sales grew across segments and was led by North America and Europe. We are moving forward with full energy on our new plan to accelerate profitable growth, built on three strategic pillars: focused segment-specific strategies, differentiated platform-based innovations, and disciplined execution.”
For Connected Care, Philips reported charges related to restructuring, acquisition-related and other items of EUR 59 million, compared with EUR 91 million in Q1 2025. This mainly includes EUR 23 million in restructuring and acquisition-related charges and EUR 34 million of Respironics-related charges.
The company has reiterated its full-year 2026 outlook:
- Comparable sales growth: 3% to 4.5%.
- Adjusted EBITA margin: 12.5% to 13.0%.
- Free cash flow: EUR 1.3 billion to 1.5 billion.
Related: Philips targets innovation, trust.
Comments